The evaluation of the repeatability of the ¹³C-ketoisocaproate breath test for assessing hepatic mitochondrial function

References

• Afolabi PR, Scorletti E, Smith DE, et al. The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the 13C-ketoisocaproate breath test. J Breath Res. 2018;12:046002. doi: 10.1088/1752-7163/aacf12
   PubMed Web of Science ®Google Scholar
• Portincasa P, Grattagliano I, Lauterburg BH, et al. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci. 2006;111:135–143. doi: 10.1042/CS20050346
   PubMed Web of Science ®Google Scholar
• Matthews DE, Harkin R, Battezzati A, et al. Splanchnic bed utilization of enteral alpha-ketoisocaproate in humans. Metab Clin Exp. 1999;48:1555–1563. doi: 10.1016/S0026-0495(99)90245-7
   PubMed Web of Science ®Google Scholar
• Berthold HK, Giesen TA, Gouni-Berthold I. The stable isotope ketoisocaproic acid breath test as a measure of hepatic decarboxylation capacity: a quantitative analysis in normal subjects after oral and intravenous administration. Liver Int. 2009;29:1356–1364. doi: 10.1111/j.1478-3231.2009.02072.x
   PubMed Web of Science ®Google Scholar
• Parra D, Gonzalez A, Garcia-Villarreal L, et al. Methodological characterization of the 2-keto[1-13C]isocaproate breath test to measure in vivo human mitochondrial function: application in alcoholic liver disease assessment. Alcohol Clin Exp Res. 2003;27:1293–1298. doi: 10.1097/01.ALC.0000081623.25175.7E
   PubMed Web of Science ®Google Scholar
• Palmieri VO, Grattagliano I, Minerva F, et al. Liver function as assessed by breath tests in patients with hepatocellular carcinoma. J Surg Res. 2009;157:199–207. doi: 10.1016/j.jss.2008.09.029
   PubMed Web of Science ®Google Scholar
• Kasicka-Jonderko A, Jonderko K, Kamińska M, et al. 13C-α-Ketoisocaproic acid breath test revisited: an in-depth reproducibility study advocates an extended breath sampling period. Dig Dis Sci. 2007;52:3481–3487. doi: 10.1007/s10620-007-9767-7
   PubMed Web of Science ®Google Scholar
• Candelli M, Armuzzi A, Miele L, et al. Gender affects 13C-ketoisocaproic acid breath test. Eur Rev Med Pharmacol Sci. 2007;11:401–406.
   PubMed Web of Science ®Google Scholar
• Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022–1030. doi: 10.1016/j.jhep.2016.12.022
   PubMed Web of Science ®Google Scholar
• Sasso M, Miette V, Sandrin L, et al. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using fibroscan. Clin Res Hepatol Gastroenterol. 2012;36:13–20. doi: 10.1016/j.clinre.2011.08.001
   PubMed Web of Science ®Google Scholar
• Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–1713. doi: 10.1016/j.ultrasmedbio.2003.07.001
   PubMed Web of Science ®Google Scholar
• Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350. doi: 10.1053/j.gastro.2004.11.018
   PubMed Web of Science ®Google Scholar
• Matthews JN, Altman DG, Campbell MJ, et al. Analysis of serial measurements in medical research. Br Med J. 1990;300:230–235. doi: 10.1136/bmj.300.6719.230
   PubMed Web of Science ®Google Scholar
• Vaz S, Falkmer T, Passmore AE, et al. The case for using the repeatability coefficient when calculating test–retest reliability. PLoS One. 2013;8:e73990. doi: 10.1371/journal.pone.0073990
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Statistics notes: measurement error. Br Med J. 1996;313:744. doi: 10.1136/bmj.313.7059.744
   PubMed Web of Science ®Google Scholar
• Darter BJ, Rodriguez KM, Wilken JM. Test–retest reliability and minimum detectable change using the K4b2: oxygen consumption, gait efficiency, and heart rate for healthy adults during submaximal walking. Res Q Exerc Sport. 2013;84:223–231. doi: 10.1080/02701367.2013.784720
   PubMed Web of Science ®Google Scholar
• Afolabi P, Wright M, Wootton S, et al. A comparison of the reproducibility of the parameters of the 13C-aminopyrine breath test for the assessment of hepatic function. Isot Environ Health Stud. 2011;47:390–399. doi: 10.1080/10256016.2011.595791
   PubMed Web of Science ®Google Scholar
• Jonderko K, Skałba P, Kamińska M, et al. Combined oral contraceptives affect liver mitochondrial activity. Eur J Contracept Reprod Health Care. 2013;18:401–409. doi: 10.3109/13625187.2013.819847
   PubMed Web of Science ®Google Scholar
• Bendtsen P, Hannestad U, Påhlsson P. Evaluation of the carbon 13-labeled ketoisocaproate breath test to assess mitochondrial dysfunction in patients with high alcohol consumption. Alcohol Clin Exp Res. 1998;22:1792–1795. doi: 10.1111/j.1530-0277.1998.tb03982.x
   PubMed Web of Science ®Google Scholar
• Grattagliano I, Lauterburg BH, Palasciano G, et al. 13C-breath tests for clinical investigation of liver mitochondrial function. Eur J Clin Invest. 2010;40:843–850. doi: 10.1111/j.1365-2362.2010.02331.x
   PubMed Web of Science ®Google Scholar
• Lamers Y, Williamson J, Theriaque DW, et al. Production of 1-carbon units from glycine is extensive in healthy men and women. J Nutr. 2009;139:666–671. doi: 10.3945/jn.108.103580
   PubMed Web of Science ®Google Scholar
• Russmann S, Junker E, Lauterburg BH. Remethylation and transsulfuration of methionine in cirrhosis: studies with l-[2H3-methyl-1-13C]methionine. Hepatology. 2002;36:1190–1196. doi: 10.1053/jhep.2002.36499
   PubMed Web of Science ®Google Scholar